Electrical impedance myography for reducing sample size in Duchenne muscular dystrophy trials
Open Access
- 25 December 2019
- journal article
- research article
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 7 (1), 4-14
- https://doi.org/10.1002/acn3.50958
Abstract
Objective To evaluate the sensitivity of electrical impedance myography (EIM) to disease progression in both ambulatory and non‐ambulatory boys with DMD. Methods and Participants A non‐blinded, longitudinal cohort study of 29 ambulatory and 15 non‐ambulatory boys with DMD and age‐similar healthy boys. Subjects were followed for up to 1 year and assessed using the Myolex® mViewTM EIM system as part of a multicenter study. Results In the ambulatory group, EIM 100 kHz resistance values showed significant change compared to the healthy boys. For example, in lower extremity muscles, the average change in EIM 100 kHz resistance values over 12 months led to an estimated effect size of 1.58. Based on these results, 26 DMD patients/arm would be needed for a 12‐month clinical trial assuming a 50% treatment effect. In non‐ambulatory boys, EIM changes were greater in upper limb muscles. For example, biceps at 100kHz resistance gave an estimated effect size of 1.92 at 12 months. Based on these results, 18 non‐ambulatory DMD patients/arm would be needed for a 12‐month clinical trial assuming a 50% treatment effect. Longitudinal changes in the 100 kHz resistance values for the ambulatory boys correlated with the longitudinal changes in the timed supine‐to‐stand test. EIM was well‐tolerated throughout the study. Interpretation This study supports that EIM 100 kHz resistance is sensitive to DMD progression in both ambulatory and non‐ambulatory boys. Given the technology’s ease of use and broad age range of utility it should be employed as an exploratory endpoint in future clinical therapeutic trials in DMD. Trial Registration: Clincialtrials.gov registration #NCT02340923Keywords
Funding Information
- National Institutes of Health (R44NS073188)
This publication has 23 references indexed in Scilit:
- Biomarkers of Duchenne muscular dystrophy: current findingsDegenerative Neurological and Neuromuscular Disease, 2018
- Quantitative muscle ultrasound detects disease progression in Duchenne muscular dystrophyAnnals of Neurology, 2017
- The NorthStar Ambulatory Assessment in Duchenne muscular dystrophy: considerations for the design of clinical trialsJournal of Neurology, Neurosurgery & Psychiatry, 2015
- Quantitative muscle ultrasound in Duchenne muscular dystrophy: A comparison of techniquesMuscle & Nerve, 2014
- Eteplirsen for the treatment of Duchenne muscular dystrophyAnnals of Neurology, 2013
- The 6‐minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter studyMuscle & Nerve, 2013
- Optimizing Electrode Configuration for Electrical Impedance Measurements of Muscle via the Finite Element MethodIEEE Transactions on Biomedical Engineering, 2013
- The 6‐minute walk test in Duchenne/Becker muscular dystrophy: Longitudinal observationsMuscle & Nerve, 2010
- The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophyMuscle & Nerve, 2009
- Test–retest reproducibility of 50kHz linear-electrical impedance myographyClinical Neurophysiology, 2006